nach oben

Erschienen in:

21.03.2022 | Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 20, 2022, Los Angeles, CA

Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022. Emerging Bone and Soft Tissue Neoplasms in the Head and Neck Region

verfasst von: Bin Xu

Erschienen in: Head and Neck Pathology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

In the past decade, several emerging bone and soft tissue neoplasms of the head and neck region have been described in the literature, including GLI1-altered mesenchymal tumors, (intraosseous) rhabdomyosarcoma with TFCP2 fusion, and adamantinoma-like Ewing sarcoma. This review provides a summary of the clinical features, histologic characteristics, immunoprofile, key diagnostic features, and differential diagnoses of these emerging entities. Notably, all three entities show epithelioid morphology and cytokeratin immunopositivity, highlighting the need to consider these mesenchymal neoplasms in the differential diagnoses of cytokeratin-positive epithelioid tumors in the head and neck region. Appropriate workups including detection of the characteristic molecular alterations are essential for the correct diagnosis.

Dahlen A, Fletcher CD, Mertens F, Fletcher JA, Perez-Atayde AR, et al. Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am J Pathol. 2004;164:1645–53.CrossRefPubMedPubMedCentral

Kerr DA, Pinto A, Subhawong TK, Wilky BA, Schlumbrecht MP, et al. Pericytoma With t(7;12) and ACTB-GLI1 Fusion: Reevaluation of an Unusual Entity and its Relationship to the Spectrum of GLI1 Fusion-related Neoplasms. Am J Surg Pathol. 2019;43:1682–92.CrossRefPubMedPubMedCentral

Antonescu CR, Agaram NP, Sung YS, Zhang L, Swanson D, et al. A distinct malignant epithelioid neoplasm with GLI1 gene rearrangements, frequent S100 protein expression, and metastatic potential: expanding the spectrum of pathologic entities with ACTB/MALAT1/PTCH1-GLI1 Fusions. Am J Surg Pathol. 2018;42:553–60.CrossRefPubMedPubMedCentral

Xu B, Chang K, Folpe AL, Kao YC, Wey SL, et al. Head and neck mesenchymal neoplasms with GLI1 gene alterations: a pathologic entity with distinct histologic features and potential for distant metastasis. Am J Surg Pathol. 2020;44:729–37.CrossRefPubMedPubMedCentral

Agaram NP, Zhang L, Sung YS, Singer S, Stevens T, et al. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions. Modern Pathol. 2019;32:1617–26.CrossRef

Nitta Y, Takeda M, Fujii T, Itami H, Tsukamoto S, et al. A case of pericytic neoplasm in the shoulder with a novel DERA-GLI1 gene fusion. Histopathology. 2021;78:466–9.CrossRefPubMed

Lopez-Nunez O, Surrey LF, Alaggio R, Herradura A, McGough RL, et al. Novel APOD-GLI1 rearrangement in a sarcoma of unknown lineage. Histopathology. 2021;78:338–40.CrossRefPubMed

Bridge JA, Sanders K, Huang D, Nelson M, Neff JR, et al. Pericytoma with t(7;12) and ACTB-GLI1 fusion arising in bone. Hum Pathol. 2012;43:1524–9.CrossRefPubMedPubMedCentral

Klubíčková N, Kinkor Z, Michal M, Baněčková M, Hájková V, et al., (2021) Epithelioid soft tissue neoplasm of the soft palate with a PTCH1-GLI1 Fusion: a case report and review of the literature. Head and Neck Pathol

10.

Dahlen A, Mertens F, Mandahl N, Panagopoulos I. Molecular genetic characterization of the genomic ACTB-GLI fusion in pericytoma with t(7;12). Biochem Biophys Res Commun. 2004;325:1318–23.CrossRefPubMed

11.

Dickson BC, Antonescu CR, Argyris PP, Bilodeau EA, Bullock MJ, et al. Ectomesenchymal chondromyxoid tumor: a neoplasm characterized by recurrent RREB1-MKL2 fusions. Am J Surg Pathol. 2018;42:1297–305.CrossRefPubMedPubMedCentral

12.

Smith BC, Ellis GL, Meis-Kindblom JM, Williams SB. Ectomesenchymal chondromyxoid tumor of the anterior tongue. Nineteen cases of a new clinicopathologic entity. Am J Surg Pathol. 1995;19:519–30.CrossRefPubMed

13.

Bubola J, Hagen K, Blanas N, Weinreb I, Dickson BC, et al. Expanding awareness of the distribution and biologic potential of ectomesenchymal chondromyxoid tumor. Head Neck Pathol. 2021;15:319–22.CrossRefPubMed

14.

Xu B, Suurmeijer AJH, Agaram NP, Zhang L, Antonescu CR. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases. Histopathology. 2021;79:347–57.CrossRefPubMed

15.

Le Loarer F, Cleven AHG, Bouvier C, Castex MP, Romagosa C, et al. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. Modern. 2020;33:404–19.

16.

Agaram NP, Zhang L, Sung YS, Cavalcanti MS, Torrence D, et al. Expanding the spectrum of intraosseous rhabdomyosarcoma: correlation between 2 distinct gene fusions and phenotype. Am J Surg Pathol. 2019;43:695–702.CrossRefPubMedPubMedCentral

17.

Watson S, Perrin V, Guillemot D, Reynaud S, Coindre JM, et al. Transcriptomic definition of molecular subgroups of small round cell sarcomas. J Pathol. 2018;245:29–40.CrossRefPubMed

18.

Dashti NK, Wehrs RN, Thomas BC, Nair A, Davila J, et al. Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype. Histopathology. 2018;73:514–20.CrossRefPubMed

19.

(2020) WHO Classification of Tumours Editorial Board. WHO classification of tumours of soft tissue and bone. World Health Organiz Classif Tumours

20.

Prieto-Granada CN, Xu B, Alzumaili B, Al Rasheed MRH, Eskander A, et al. Clinicopathologic features and outcome of head and neck mucosal spindle cell squamous cell carcinoma. Virchows Arch. 2021;479:729–39.CrossRefPubMed

21.

Thompson LD, Wieneke JA, Miettinen M, Heffner DK. Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases. Am J Surg Pathol. 2002;26:153–70.CrossRefPubMed

22.

Viswanathan S, Rahman K, Pallavi S, Sachin J, Patil A, et al. Sarcomatoid (spindle cell) carcinoma of the head and neck mucosal region: a clinicopathologic review of 103 cases from a tertiary referral cancer centre. Head Neck Pathol. 2010;4:265–75.CrossRefPubMedPubMedCentral

23.

Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, et al. Adamantinoma-like Ewing’s sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol. 1999;23:159–65.CrossRefPubMed

24.

Rooper LM, Bishop JA, (2020) Soft tissue special issue: adamantinoma-like ewing sarcoma of the head and neck: a practical review of a challenging emerging entity. Head Neck Pathol 14:59–69

25.

Rooper LM, Jo VY, Antonescu CR, Nose V, Westra WH, et al. Adamantinoma-like ewing sarcoma of the salivary glands: a newly recognized mimicker of basaloid salivary carcinomas. Am J Surg Pathol. 2019;43:187–94.CrossRefPubMedPubMedCentral

26.

Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015;39:1267–74.CrossRefPubMedPubMedCentral

27.

Weinreb I, Goldstein D, Perez-Ordoñez B. Primary extraskeletal Ewing family tumor with complex epithelial differentiation: a unique case arising in the lateral neck presenting with Horner syndrome. Am J Surg Pathol. 2008;32:1742–8.CrossRefPubMed

28.

Ongkeko M, Zeck J, de Brito P. Molecular testing uncovers an adamantinoma-like ewing family of tumors in the thyroid: case report and review of literature. AJSP: Rev Rep. 2018;23:8–12.

29.

Oliveira G, Polónia A, Cameselle-Teijeiro JM, Leitão D, Sapia S, et al. EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE). Virchows Arch. 2017;470:517–25.CrossRefPubMed

30.

McCuiston A, Bishop JA. Usefulness of NKX2.2 immunohistochemistry for distinguishing ewing sarcoma from other sinonasal small round blue cell tumors. Head Neck Pathol. 2018;12:89–94.CrossRefPubMed

Titel: Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022. Emerging Bone and Soft Tissue Neoplasms in the Head and Neck Region
verfasst von: Bin Xu
Publikationsdatum: 21.03.2022
Verlag: Springer US
Erschienen in: Head and Neck Pathology / Ausgabe 1/2022
Elektronische ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-022-01418-9

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022. Emerging Bone and Soft Tissue Neoplasms in the Head and Neck Region

Abstract

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Oral Lymphoepithelial Cyst: A Collaborative Clinicopathologic Study of 132 Cases from Brazil

High Rates of Ultraviolet-Signature Mutations in Squamous Cell Carcinomas of the Parotid Gland and Prognostic Implications

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Soft Tissue Tumors

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Familial Tumor Syndromes

Correction to: Mutually Exclusive Expression of COL11A1 by CAFs and Tumour Cells in a Large panCancer and a Salivary Gland Carcinoma Cohort

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren